Dr. Reddy's Laboratories Limited (RDY) Securities Fraud Investigation - Levi & Korsinsky
NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Dr. Reddy's Laboratories Limited ("Dr. Reddy's Laboratories Limited") (NYSE:RDY) concerning potential violations of the federal securities laws.
On July 22, 2026, Dr. Reddy's Laboratories shares fell approximately 9% after the Company reported a Q1 FY27 earnings miss and disclosed a 2.4 billion provision tied to out-of-spec semaglutide batches.
On the related call, Chief Executive Officer Erez Israeli stated there was "no impact on the product's existing global regulatory filings" and "no patient-safety impact associated with product already supplied to the market." The same update followed Dr. Reddy's prior statements highlighting semaglutide approvals and launches, including Obeda in Canada and oral semaglutide approval in India.
The investigation concerns whether investors were adequately informed about the semaglutide batch issue, the related provision, and the financial exposure before RDY shares declined approximately 9%.
If you suffered a loss on your Dr. Reddy's Laboratories Limited securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
SOURCE: Levi & Korsinsky, LLP